Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp V.QIPT


Primary Symbol: T.QIPT Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Post by TallerCraigon Feb 26, 2020 1:36am
227 Views
Post# 30733942

Q1 Estimate - $22.2M Revenue w $4.1M EBITDA

Q1 Estimate - $22.2M Revenue w $4.1M EBITDAAdd in partial Cooley & Acadia acqusition and throw a futher point or two or organic growth QoQ and we are $22.2M which would be a solid 15% QoQ growth rate. 

It will take a Q or 2 to intergrate the acquisitions into the exsisiting business so you might get a slight temp down tick on EBITDA margin so using a 18.5% figure which would be $4.1M which would be a solid 11% QoQ growth rate.

Double digit grower trading at 4x EBITDA with acquisition program to accelerate. 

Keep an eye on FCF...as the business becomes more recurring in nature driven by more sales vs equipment the FCF profile should start to improve. This is what will drive the valuation expansion.  Any update on bank financing or further acquisitions will be critical.
Bullboard Posts